$5650 | Single User
$6650 | Multi User
$8150 | Corporate License
$10000 | Global License

Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer), Product, and End Users & Region - Global Forecast to 2020
[Lowest Price Guaranteed: $5,650]

Published by MarketsandMarkets: 02 Dec 2015 | 42256 | In Stock

Introduction

The global tissue diagnostics market is valued at USD 3,202.5 million in 2015 and expected to reach USD 4,471.1 million by 2020, at a CAGR of 6.9% from 2015 to 2020. The global tissue diagnostics market is segmented based on products, technology, diseases, and end users. On the basis of product, the tissue diagnostics market is segmented into instruments and consumables. The instruments product segment is further subsegmented into slide-staining systems, scanners, tissue-processing systems, and other instruments. Other instruments include digital pathology systems and histology equipment like automated cover slippers, microtomes, paraffin dispensers, and slide labelers. Consumables product segment is further subsegmented into antibodies, kits, reagents, and probes.

On the basis of technology, the tissue diagnostics market is segmented into immunohistochemistry, in situ hybridization, digital pathology and workflow, and special staining. On the basis of diseases, the tissue diagnostics market is segmented into breast cancer, gastric cancer, lymphoma, prostate cancer, NSCLC, and other diseases. On the basis of end user, the tissue diagnostics market is segmented into hospitals, pharmaceutical companies, research laboratories, contract research organizations, and other end users.

The geographic segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW). The geographic analysis reveals that North America accounted for the largest share in the global tissue diagnostics market in 2015. Asia, on the other hand, is expected to register faster growth during 2015 to 2020.

The key drivers for this market are the increasing prevalence of cancer, growing geriatric population, and growing healthcare expenditure. On the other hand, the high degree of consolidation, stringent regulatory requirements, and lack of budgets are restraining the growth of this market.

A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global tissue diagnostics market and its subsegments. Secondary information was used to identify the overall revenues, geographic reach, and product portfolios of market players. Estimates of their tissue diagnostics product segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine percentage shares of each subsegment and the relative differences in growth rates.

The report provides qualitative insights about key market shares, growth rates, and market drivers for all important subsegments. It maps the market sizes and growth rates of each subsegment and identifies the segments expected to see rapid growth in each geographic segment. The report also includes company profiles of market leaders. These company profiles include financial performances, product portfolios, and market developments for each company. The report also provides a competitive landscape of the tissue diagnostics market. The competitive landscape covers the growth strategies adopted by industry players over the last four years. It also includes an analysis of industry developments.

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.

The report provides insights on the following:

• Product Development: Product portfolios of the top players in the tissue diagnostics market.

• Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of the leading players in the tissue diagnostics market.

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various tissue diagnostics products across geographies.

Table of Contents
for Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer), Product, and End Users & Region - Global Forecast to 2020

  • TABLE OF CONTENTS

    1 INTRODUCTION 16

    1.1 OBJECTIVES OF THE STUDY 16

    1.2 MARKET DEFINITION 16

    1.3 MARKET SCOPE 17

    1.3.1 MARKETS COVERED 17

    1.3.2 YEARS CONSIDERED FOR THE STUDY 17

    1.4 CURRENCY 18

    1.5 LIMITATIONS 18

    1.6 STAKEHOLDERS 18

    2 RESEARCH METHODOLOGY 19

    2.1 MARKET SIZE ESTIMATION 20

    2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 22

    2.3 MARKET SHARE ESTIMATION 23

    2.3.1 KEY DATA FROM SECONDARY SOURCES 24

    2.3.2 KEY DATA FROM PRIMARY SOURCES 24

    2.3.3 ASSUMPTIONS FOR THE STUDY 25

    3 EXECUTIVE SUMMARY 26

    4 PREMIUM INSIGHTS 31

    4.1 GLOBAL TISSUES DIAGNOSTICS MARKET OVERVIEW 31

    4.2 LIFE CYCLE ANALYSIS, BY REGION 34

    5 MARKET OVERVIEW 35

    5.1 INTRODUCTION 36

    5.1.1 BY DISEASE 36

    5.1.2 BY END USER 37

    5.1.3 BY PRODUCT 37

    5.1.4 BY TECHNOLOGY 37

    5.2 MARKET DYNAMICS 38

    5.2.1 DRIVERS 39

    5.2.1.1 Rising incidences of cancer 39

    5.2.1.2 Rapidly increasing aging population 39

    5.2.1.3 Growing healthcare expenditure 39

    5.2.2 RESTRAINTS 41

    5.2.2.1 Stringent regulatory requirements and compliance 41

    5.2.2.2 High degree of consolidation 41

    5.2.2.3 Budget constraints 41

    5.2.3 OPPORTUNITIES 42

    5.2.3.1 High growth in emerging markets 42

    5.2.3.2 Increased use of personalized medicine 43

    5.2.4 TREND 43

    5.2.4.1 Increasing number of reagent rental agreements 43

    6 TISSUE DIAGNOSTICS MARKET, BY PRODUCT 45

    6.1 INTRODUCTION 46

    6.2 CONSUMABLES 47

    6.2.1 ANTIBODIES 50

    6.2.2 KITS 51

    6.2.3 REAGENTS 52

    6.2.4 PROBES 53

    6.3 INSTRUMENTS 54

    6.3.1 SLIDE-STAINING SYSTEMS 57

    6.3.2 SCANNERS 58

    6.3.3 TISSUE-PROCESSING SYSTEMS 59

    6.3.4 OTHER INSTRUMENTS 60

    7 TISSUE DIAGNOSTICS MARKET, BY DISEASES 61

    7.1 INTRODUCTION 62

    7.2 BREAST CANCER 64

    7.3 GASTRIC CANCER 66

    7.4 LYMPHOMA 67

    7.5 PROSTATE CANCER 69

    7.6 NON-SMALL CELL LUNG CANCER 70

    7.7 OTHER DISEASES 72

    8 TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY 74

    8.1 INTRODUCTION 75

    8.2 IMMUNOHISTOCHEMISTRY (IHC) 76

    8.3 IN SITU HYBRIDIZATION (ISH) 78

    8.4 DIGITAL PATHOLOGY AND WORKFLOW MANAGEMENT 79

    8.5 SPECIAL STAINING 81

    9 TISSUE DIAGNOSTICS MARKET, BY END USER 83

    9.1 INTRODUCTION 84

    9.2 HOSPITALS 85

    9.3 RESEARCH LABORATORIES 87

    9.4 PHARMACEUTICAL COMPANIES 88

    9.5 CONTRACT RESEARCH ORGANIZATIONS 89

    9.6 OTHER END USERS 91

    10 TISSUE DIAGNOSTICS MARKET, BY REGION 92

    10.1 INTRODUCTION 93

    10.2 NORTH AMERICA 95

    10.2.1 U.S. 102

    10.2.2 CANADA 104

    10.3 EUROPE 107

    10.4 ASIA 113

    10.5 REST OF THE WORLD (ROW) 120

    11 COMPETITIVE LANDSCAPE 127

    11.1 INTRODUCTION 127

    11.2 STRATEGIC OVERVIEW 127

    11.3 LEADING PLAYERS IN THE TISSUE DIAGNOSTICS MARKET 128

    11.4 COMPETITIVE SITUATION AND TRENDS 130

    11.4.1 NEW PRODUCTS LAUNCHES AND PRODUCT UPGRADES 131

    11.4.2 ACQUISITIONS 132

    11.4.3 EXPANSIONS 133

    11.4.4 AGREEMENTS, COLLABORATIONS, CONTRACTS, MARKETING INITIATIVES, AND PARTNERSHIPS 133

    11.4.5 OTHER DEVELOPMENTS 134

    12 COMPANY PROFILES 135

    12.1 INTRODUCTION 135

    12.2 ABBOTT LABORATORIES, INC. 136

    12.3 AGILENT TECHNOLOGIES, INC. 139

    12.4 BIO SB 142

    12.5 BIOGENEX LABORATORIES 144

    12.6 CELL SIGNALING TECHNOLOGY, INC. 146

    12.7 DANAHER CORPORATION 148

    12.8 F. HOFFMAN-LA ROCHE AG 151

    12.9 SAKURA FINETEK JAPAN CO., LTD. 154

    12.10 SIGMA-ALDRICH CORPORATION 156

    12.11 THERMO FISHER SCIENTIFIC 159

    *Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.

    13 APPENDIX 162

    13.1 INSIGHTS OF INDUSTRY EXPERTS 162

    13.2 DISCUSSION GUIDE 163

    13.3 OTHER DEVELOPMENTS 165

    13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 173

    13.5 AVAILABLE CUSTOMIZATIONS 174

    13.6 RELATED REPORTS 175

List Of Tables
in Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer), Product, and End Users & Region - Global Forecast to 2020

LIST OF TABLES


TABLE 1 TISSUE DIAGNOSTICS MARKET SUMMARY 26

TABLE 2 RISING INCIDENCES OF CANCER ARE THE PRIMARY DRIVER FOR THE TISSUE DIAGNOSTICS MARKET 40

TABLE 3 STRINGENT REGULATORY REQUIREMENTS IS A KEY RESTRAINT FOR THE GROWTH OF THE TISSUE DIAGNOSTICS MARKET 42

TABLE 4 EMERGING ECONOMIES PRESENT SIGNIFICANT GROWTH OPPORTUNITIES 43

TABLE 5 INCREASING NUMBER OF REAGENT RENTAL AGREEMENTS IS A MAJOR TREND FOR THE GROWTH OF THIS MARKET 44

TABLE 6 TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION) 47

TABLE 7 TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES,

2013–2020 (USD MILLION) 48

TABLE 8 TISSUE DIAGNOSTICS MARKET SIZE FOR CONSUMABLES, BY REGION,

2013–2020 (USD MILLION) 49

TABLE 9 TISSUE DIAGNOSTICS MARKET SIZE FOR ANTIBODIES, BY REGION,

2013–2020 (USD MILLION) 51

TABLE 10 TISSUE DIAGNOSTICS MARKET SIZE FOR KITS, BY REGION,

2013–2020 (USD MILLION) 52

TABLE 11 TISSUE DIAGNOSTICS MARKET SIZE FOR REAGENTS, BY REGION,

2013–2020 (USD MILLION) 53

TABLE 12 TISSUE DIAGNOSTICS MARKET SIZE FOR PROBES, BY REGION,

2013–2020 (USD MILLION) 54

TABLE 13 TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENT, 2013–2020 (USD MILLION) 55

TABLE 14 TISSUE DIAGNOSTICS MARKET SIZE FOR INSTRUMENTS, BY REGION,

2013–2020 (USD MILLION) 56

TABLE 15 TISSUE DIAGNOSTICS MARKET SIZE FOR SLIDE-STAINING SYSTEMS, BY REGION, 2013–2020 (USD MILLION) 57

TABLE 16 TISSUE DIAGNOSTICS MARKET SIZE FOR SCANNERS, BY REGION,

2013–2020 (USD MILLION) 58

TABLE 17 TISSUE DIAGNOSTICS MARKET SIZE FOR TISSUE-PROCESSING SYSTEMS,

BY REGION, 2013–2020 (USD MILLION) 59

TABLE 18 TISSUE DIAGNOSTICS MARKET SIZE FOR OTHER INSTRUMENTS, BY REGION, 2013–2020 (USD MILLION) 60

TABLE 19 TISSUE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2013–2020 (USD MILLION) 63

TABLE 20 TISSUE DIAGNOSTICS MARKET SIZE FOR BREAST CANCER, BY REGION,

2013–2020 (USD MILLION) 65

TABLE 21 TISSUE DIAGNOSTICS MARKET SIZE FOR GASTRIC CANCER, BY REGION,

2013–2020 (USD MILLION) 67

TABLE 22 TISSUE DIAGNOSTICS MARKET SIZE FOR LYMPHOMA, BY REGION,

2013-2020 (USD MILLION) 68

TABLE 23 TISSUE DIAGNOSTICS MARKET SIZE FOR PROSTATE CANCER, BY REGION,

2013–2020 (USD MILLION) 70

TABLE 24 TISSUE DIAGNOSTICS MARKET SIZE FOR NON-SMALL CELL LUNG CANCER,

BY REGION, 2013–2020 (USD MILLION) 71

TABLE 25 TISSUE DIAGNOSTICS MARKET SIZE FOR OTHER DISEASES, BY REGION,

2013–2020 (USD MILLION) 73

TABLE 26 TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,

2013–2020 (USD MILLION) 75

TABLE 27 TISSUE DIAGNOSTICS MARKET SIZE FOR IMMUNOHISTOCHEMISTRY, BY REGION, 2013–2020 (USD MILLION) 77

TABLE 28 TISSUE DIAGNOSTICS MARKET SIZE FOR IN SITU HYBRIDIZATION, BY REGION, 2013–2020 (USD MILLION) 79

TABLE 29 TISSUE DIAGNOSTICS MARKET SIZE FOR DIGITAL PATHOLOGY AND WORKFLOW MANAGEMENT, BY REGION, 2013-2020 (USD MILLION) 80

TABLE 30 TISSUE DIAGNOSTICS MARKET SIZE FOR SPECIAL STAINING, BY REGION,

2013–2020 (USD MILLION) 82

TABLE 31 TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2013–2020 (USD MILLION) 85

TABLE 32 TISSUE DIAGNOSTICS MARKET SIZE FOR HOSPITALS, BY REGION,

2013–2020 (USD MILLION) 86

TABLE 33 TISSUE DIAGNOSTICS MARKET SIZE FOR RESEARCH LABORATORIES, BY REGION, 2013–2020 (USD MILLION) 88

TABLE 34 TISSUE DIAGNOSTICS MARKET SIZE FOR PHARMACEUTICAL COMPANIES,

BY REGION, 2013-2020 (USD MILLION) 89

TABLE 35 TISSUE DIAGNOSTICS MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2013–2020 (USD MILLION) 90

TABLE 36 TISSUE DIAGNOSTICS MARKET SIZE FOR OTHER END USERS, BY REGION,

2013–2020 (USD MILLION) 91

TABLE 37 TISSUE DIAGNOSTICS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 94

TABLE 38 NORTH AMERICA: TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY,

2013–2020 (USD MILLION) 96

TABLE 39 NORTH AMERICA: TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT,

2013–2020 (USD MILLION) 97

TABLE 40 NORTH AMERICA: TISSUE DIAGNOSTICS MARKET SIZE FOR CONSUMABLES,

BY TYPE, 2013–2020 (USD MILLION) 98

TABLE 41 NORTH AMERICA: TISSUE DIAGNOSTICS MARKET SIZE FOR INSTRUMENTS,

BY TYPE, 2013–2020 (USD MILLION) 99

TABLE 42 NORTH AMERICA: TISSUE DIAGNOSTICS MARKET SIZE, BY DISEASE,

2013–2020 (USD MILLION) 100

TABLE 43 NORTH AMERICA: TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,

2013–2020 (USD MILLION) 101

TABLE 44 NORTH AMERICA: TISSUE DIAGNOSTICS MARKET SIZE, BY END USER,

2013–2020 (USD MILLION) 102

TABLE 45 U.S.: TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT,

2013–2020 (USD MILLION) 103

TABLE 46 U.S.: TISSUE DIAGNOSTICS MARKET SIZE, BY DISEASE,

2013–2020 (USD MILLION) 103

TABLE 47 U.S.: TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,

2013–2020 (USD MILLION) 104

TABLE 48 U.S.: TISSUE DIAGNOSTICS MARKET SIZE, BY END USER,

2013–2020 (USD MILLION) 104

TABLE 49 CANADA: TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT,

2013–2020 (USD MILLION) 105

TABLE 50 CANADA: TISSUE DIAGNOSTICS MARKET SIZE, BY DISEASE,

2013–2020 (USD MILLION) 106

TABLE 51 CANADA: TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,

2013–2020 (USD MILLION) 106

TABLE 52 CANADA: TISSUE DIAGNOSTICS MARKET SIZE, BY END USER,

2013–2020 (USD MILLION) 107

TABLE 53 EUROPE: TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT,

2013–2020 (USD MILLION) 108

TABLE 54 EUROPE: TISSUE DIAGNOSTICS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013–2020 (USD MILLION) 109

TABLE 55 EUROPE: TISSUE DIAGNOSTICS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013–2020 (USD MILLION) 110

TABLE 56 EUROPE: TISSUE DIAGNOSTICS MARKET SIZE, BY DISEASE,

2013–2020 (USD MILLION) 111

TABLE 57 EUROPE: TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,

2013–2020 (USD MILLION) 112

TABLE 58 EUROPE: TISSUE DIAGNOSTICS MARKET SIZE, BY END USER,

2013–2020 (USD MILLION) 113

TABLE 59 ASIA: TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT,

2013–2020 (USD MILLION) 115

TABLE 60 ASIA: TISSUE DIAGNOSTICS MARKET SIZE FOR CONSUMABLES, BY TYPE,

2013–2020 (USD MILLION) 116

TABLE 61 ASIA: TISSUE DIAGNOSTICS MARKET SIZE FOR INSTRUMENTS, BY TYPE,

2013–2020 (USD MILLION) 117

TABLE 62 ASIA: TISSUE DIAGNOSTICS MARKET SIZE, BY DISEASE,

2013–2020 (USD MILLION) 118

TABLE 63 ASIA: TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,

2013–2020 (USD MILLION) 119

TABLE 64 ASIA: TISSUE DIAGNOSTICS MARKET SIZE, BY END USER,

2013–2020 (USD MILLION) 120

TABLE 65 ROW: TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT,

2013–2020 (USD MILLION) 121

TABLE 66 ROW: TISSUE DIAGNOSTICS MARKET SIZE FOR CONSUMABLES, BY TYPE,

2013–2020 (USD MILLION) 122

TABLE 67 ROW: TISSUE DIAGNOSTICS MARKET SIZE FOR INSTRUMENTS, BY TYPE,

2013–2020 (USD MILLION) 123

TABLE 68 ROW: TISSUE DIAGNOSTICS MARKET SIZE, BY DISEASE,

2013–2020 (USD MILLION) 124

TABLE 69 ROW: TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,

2013–2020 (USD MILLION) 125

TABLE 70 ROW: TISSUE DIAGNOSTICS MARKET SIZE, BY END USER,

2013–2020 (USD MILLION) 126

TABLE 71 MARKET DEVELOPMENTS BETWEEN 2012 AND 2015 130

TABLE 72 NEW PRODUCT LAUNCHES AND PRODUCT UPGRADES, 2012–2015 131

TABLE 73 ACQUISITIONS, 2012–2015 132

TABLE 74 EXPANSIONS, 2012–2015 133

TABLE 75 AGREEMENTS, COLLABORATIONS, CONTRACTS, MARKETING INITIATIVES, AND PARTNERSHIPS, 2012–2015 133

TABLE 76 OTHER DEVELOPMENTS, 2012–2015 134

List Of Figures, Charts and Diagrams
in Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer), Product, and End Users & Region - Global Forecast to 2020

LIST OF FIGURES


FIGURE 1 GLOBAL TISSUE DIAGNOSTICS MARKET 17

FIGURE 2 RESEARCH DESIGN 19

FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 21

FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 21

FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,

AND REGION 22

FIGURE 6 DATA TRIANGULATION METHODOLOGY 23

FIGURE 7 TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2015 VS. 2020 (USD MILLION) 27

FIGURE 8 TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,

2015 VS. 2020 (USD MILLION) 27

FIGURE 9 TISSUE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2015 VS. 2020 (USD MILLION) 28

FIGURE 10 TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2015 VS. 2020 (USD MILLION) 29

FIGURE 11 TISSUE DIAGNOSTICS MARKET SIZE, BY REGION, 2015 VS. 2020 (USD MILLION) 30

FIGURE 12 RISING INCIDENCES OF CANCER TO DRIVE MARKET GROWTH 31

FIGURE 13 IMMUNOHISTOCHEMISTRY SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2015 32

FIGURE 14 ASIA TO WITNESS HIGHEST GROWTH RATE IN THE FORECAST PERIOD

(2015 TO 2020) 33

FIGURE 15 ASIA HOLDS LUCRATIVE GROWTH OPPORTUNITIES 34

FIGURE 16 TISSUE DIAGNOSTICS MARKET, BY DISEASE 36

FIGURE 17 TISSUE DIAGNOSTICS MARKET, BY END USER 37

FIGURE 18 TISSUE DIAGNOSTICS MARKET, BY PRODUCT 37

FIGURE 19 TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY 37

FIGURE 20 INCREASING INCIDENCES OF CANCER ARE EXPECTED TO DRIVE THE TISSUE DIAGNOSTICS MARKET DURING THE FORECAST PERIOD 38

FIGURE 21 INCREASING HEALTHCARE EXPENDITURE WILL DRIVE THE TISSUE DIAGNOSTICS MARKET 40

FIGURE 22 RAPID GROWTH IN HEALTHCARE EXPENDITURE IN EMERGING MARKETS IS AN IMPORTANT GROWTH OPPORTUNITY 42

FIGURE 23 TISSUE DIAGNOSTICS MARKET, BY PRODUCT 46

FIGURE 24 TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2015 (USD MILLION) 46

FIGURE 25 TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2015 (USD MILLION) 48

FIGURE 26 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE CONSUMABLES PRODUCT SEGMENT IN 2015 49

FIGURE 27 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE ANTIBODIES PRODUCT SEGMENT IN 2015 50

FIGURE 28 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE KITS PRODUCT SEGMENT IN 2015 51

FIGURE 29 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE REAGENTS PRODUCT SEGMENT IN 2015 52

FIGURE 30 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE PROBES PRODUCT SEGMENT IN 2015 53

FIGURE 31 TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENT, 2015 (USD MILLION) 55

FIGURE 32 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE INSTRUMENTS PRODUCT SEGMENT IN 2015 56

FIGURE 33 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE SLIDE-STAINING SYSTEMS PRODUCT SEGMENT IN 2015 57

FIGURE 34 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE SCANNERS PRODUCT SEGMENT IN 2015 58

FIGURE 35 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE TISSUE-PROCESSING SYSTEMS PRODUCT SEGMENT IN 2015 59

FIGURE 36 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE OTHER INSTRUMENTS PRODUCT SEGMENT IN 2015 60

FIGURE 37 TISSUE DIAGNOSTICS MARKET, BY DISEASE 62

FIGURE 38 TISSUE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2015 (USD MILLION) 63

FIGURE 39 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE BREAST CANCER DISEASE SEGMENT IN 2015 65

FIGURE 40 ASIA TO BE THE FASTEST-GROWING SEGMENT IN THE TISSUE DIAGNOSTICS MARKET FOR GASTRIC CANCER DURING THE FORECAST PERIOD 66

FIGURE 41 ASIA TO WITNESS HIGHEST GROWTH IN THE LYMPHOMA DISEASE SEGMENT DURING THE FORECAST PERIOD 68

FIGURE 42 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE PROSTATE CANCER DISEASE SEGMENT IN 2015 69

FIGURE 43 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE NON-SMALL CELL LUNG CANCER DISEASE SEGMENT IN 2015 71

FIGURE 44 ASIA TO BE THE FASTEST-GROWING MARKET IN THE OTHER DISEASES SEGMENT DURING THE FORECAST PERIOD 72

FIGURE 45 TISSUE DIAGNOSTICS MARKET SEGMENTATION, BY TECHNOLOGY 75

FIGURE 46 TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2015 (USD MILLION) 75

FIGURE 47 NORTH AMERICA TO DOMINATE THE IMMUNOHISTOCHEMISTRY TECHNOLOGY SEGMENT IN 2015 77

FIGURE 48 ASIA TO BE THE FASTEST-GROWING MARKET IN THE IN SITU HYBRIDIZATION TECHNOLOGY SEGMENT DURING THE FORECAST PERIOD 78

FIGURE 49 ASIA TO WITNESS HIGHEST GROWTH IN THE DIGITAL PATHOLOGY AND WORKFLOW MANAGEMENT TECHNOLOGY SEGMENT DURING THE FORECAST PERIOD 80

FIGURE 50 NORTH AMERICA TO DOMINATE THE SPECIAL STAINING TECHNOLOGY

SEGMENT IN 2015 81

FIGURE 51 TISSUE DIAGNOSTICS MARKET SEGMENTATION, BY END USER 84

FIGURE 52 TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2015 (USD MILLION) 84

FIGURE 53 NORTH AMERICA TO DOMINATE THE HOSPITAL END-USER SEGMENT IN 2015 86

FIGURE 54 THE RESEARCH LABORATORIES END-USER SEGMENT IN ASIA TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD 87

FIGURE 55 PHARMACEUTICAL COMPANIES SEGMENT IN ASIA TO WITNESS HIGHEST GROWTH IN THE FORECAST PERIOD 88

FIGURE 56 NORTH AMERICA TO DOMINATE THE CONTRACT RESEARCH ORGANIZATIONS END-USER SEGMENT IN 2015 90

FIGURE 57 NORTH AMERICA TO DOMINATE THE OTHER END-USERS SEGMENT IN 2015 91

FIGURE 58 TISSUE DIAGNOSTICS MARKET SEGMENTATION, BY REGION 93

FIGURE 59 NORTH AMERICA TO DOMINATE THE GLOBAL TISSUE DIAGNOSTICS MARKET

IN 2015 93

FIGURE 60 TISSUE DIAGNOSTICS MARKET IN ASIA TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 94

FIGURE 61 NORTH AMERICA: MARKET SNAPSHOT 95

FIGURE 62 U.S. IS EXPECTED TO BE THE FASTEST-GROWING MARKET IN NORTH AMERICA

IN 2015 96

FIGURE 63 CONSUMABLES TO COMMAND THE LARGEST SHARE OF THE TISSUE DIAGNOSTICS MARKET IN NORTH AMERICA DURING THE FORECAST PERIOD 97

FIGURE 64 ANTIBODIES TO DOMINATE THE TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES IN NORTH AMERICA DURING THE FORECAST PERIOD 98

FIGURE 65 SLIDE STAINING SYSTEMS TO DOMINATE THE TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES IN NORTH AMERICA DURING THE FORECAST PERIOD 99

FIGURE 66 BREAST CANCER TO FORM THE LARGEST DISEASE SEGMENT IN NORTH AMERICA IN 2015 100

FIGURE 67 IMMUNOHISTOCHEMISTRY TO FORM THE LARGEST TECHNOLOGY SEGMENT IN NORTH AMERICA IN 2015 101

FIGURE 68 HOSPITALS TO FORM THE LARGEST END-USER SEGMENT IN NORTH AMERICA

IN 2015 101

FIGURE 69 CONSUMABLES TO COMMAND THE LARGEST SHARE OF THE TISSUE DIAGNOSTICS MARKET IN EUROPE DURING THE FORECAST PERIOD 108

FIGURE 70 ANTIBODIES TO DOMINATE THE TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES IN EUROPE DURING THE FORECAST PERIOD 109

FIGURE 71 SLIDE STAINING SYSTEMS TO DOMINATE THE TISSUE DIAGNOSTICS MARKET FOR INSTRUMENTS IN EUROPE DURING THE FORECAST PERIOD 110

FIGURE 72 BREAST CANCER TO FORM THE LARGEST DISEASE SEGMENT IN EUROPE IN 2015 111

FIGURE 73 IMMUNOHISTOCHEMISTRY TO FORM THE LARGEST TECHNOLOGY SEGMENT IN EUROPE IN 2015 112

FIGURE 74 HOSPITALS TO FORM THE LARGEST END-USER SEGMENT IN EUROPE IN 2015 112

FIGURE 75 ASIA: MARKET SNAPSHOT 114

FIGURE 76 CONSUMABLES TO COMMAND THE LARGEST SHARE OF THE TISSUE DIAGNOSTICS MARKET IN ASIA DURING THE FORECAST PERIOD 115

FIGURE 77 ANTIBODIES TO DOMINATE THE TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES IN ASIA DURING THE FORECAST PERIOD 116

FIGURE 78 SLIDE STAINING SYSTEMS TO DOMINATE THE TISSUE DIAGNOSTICS MARKET FOR INSTRUMENTS IN ASIA DURING THE FORECAST PERIOD 117

FIGURE 79 BREAST CANCER TO FORM THE LARGEST DISEASE SEGMENT IN ASIA IN 2015 118

FIGURE 80 IMMUNOHISTOCHEMISTRY TO FORM THE LARGEST TECHNOLOGY SEGMENT IN ASIA IN 2015 119

FIGURE 81 HOSPITALS TO FORM THE LARGEST END-USER SEGMENT IN ASIA IN 2015 119

FIGURE 82 CONSUMABLES COMMAND THE LARGEST SHARE OF THE TISSUE DIAGNOSTICS MARKET IN ROW DURING THE FORECAST PERIOD 121

FIGURE 83 ANTIBODIES TO DOMINATE THE TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES IN ROW DURING THE FORECAST PERIOD BETWEEN 2015–2020 122

FIGURE 84 SLIDE STAINING SYSTEMS TO DOMINATE THE TISSUE DIAGNOSTICS MARKET FOR INSTRUMENTS IN ROW DURING THE FORECAST PERIOD 123

FIGURE 85 BREAST CANCER TO FORM THE LARGEST DISEASE SEGMENT IN ROW IN 2015 124

FIGURE 86 IMMUNOHISTOCHEMISTRY TO FORM THE LARGEST TECHNOLOGY SEGMENT IN ROW IN 2015 125

FIGURE 87 HOSPITALS TO FORM THE LARGEST END-USER SEGMENT IN ROW IN 2015 125

FIGURE 88 KEY DEVELOPMENTS IN THE TISSUE DIAGNOSTICS MARKET, 2010-2015 127

FIGURE 89 TISSUE DIAGNOSTICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015 128

FIGURE 90 SNAPSHOT OF THE FINANCIAL PERFORMANCES OF THE LEADING MARKET PLAYERS 135

FIGURE 91 ABBOTT LABORATORIES, INC.: COMPANY SNAPSHOT 136

FIGURE 92 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT 139

FIGURE 93 DANAHER CORPORATION: COMPANY SNAPSHOT 148

FIGURE 94 F. HOFFMAN-LA ROCHE AG: COMPANY SNAPSHOT 151

FIGURE 95 SIGMA-ALDRICH CORPORATION: COMPANY SNAPSHOT 156

FIGURE 96 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT 159

Additional Details

Publisher

MarketsandMarkets

Publisher Information

Reference

42256 | MD 2349

Number of Pages

176

Report Format

PDF

MarketsandMarkets Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Tissue Regenix Ltd - Medical Equipment - Deals and Alliances Profile
SummaryTissue Regenix Ltd (Tissue Regenix) is a medical technology company that offers replacement b...
27 Feb 2016 by Global Data USD $250 More Info
Tissue Therapies Limited (TIS) - Medical Equipment - Deals and Alliances Profile
SummaryTissue Therapies Limited (TTL) is a heath biotechnology company that develops, manufactures a...
27 Feb 2016 by Global Data USD $250 More Info
Soft Tissue Regeneration, Inc. - Medical Equipment - Deals and Alliances Profile
SummarySoft Tissue Regeneration, Inc. (STR) is a medical device company that develops technology for...
27 Feb 2016 by Global Data USD $250 More Info
Tissue Therapies Limited (TIS) - Financial and Strategic SWOT Analysis Review
SummaryTissue Therapies Limited (TTL) is a heath biotechnology company that develops, manufactures a...
09 Jan 2016 by Global Data USD $300 More Info
Japan Tissue Engineering Co., Ltd. (7774) - Financial and Strategic SWOT Analysis Review
SummaryJapan Tissue Engineering Co., Ltd. (J-TEC) is a Pharmaceutical and Medical Device company tha...
09 Jan 2016 by Global Data USD $300 More Info
Tissue Therapies Limited (TIS) - Financial and Strategic SWOT Analysis Review
SummaryTissue Therapies Limited (TTL) is a heath biotechnology company that develops, manufactures a...
08 Nov 2015 by Global Data USD $300 More Info
Japan Tissue Engineering Co., Ltd. (7774) - Financial and Strategic SWOT Analysis Review
SummaryJapan Tissue Engineering Co., Ltd. (J-TEC) is a Pharmaceutical and Medical Device company tha...
08 Nov 2015 by Global Data USD $300 More Info
Tissue Regenix Ltd - Medical Equipment - Deals and Alliances Profile
SummaryTissue Regenix Ltd (Tissue Regenix) is a medical technology company that offers replacement b...
03 Nov 2015 by Global Data USD $250 More Info
Tissue Genesis, Inc. - Medical Equipment - Deals and Alliances Profile
SummaryTissue Genesis, Inc. (TGI) is biotechnology company that provides services in the area of tis...
03 Nov 2015 by Global Data USD $250 More Info
Soft Tissue Regeneration, Inc. - Medical Equipment - Deals and Alliances Profile
SummarySoft Tissue Regeneration, Inc. (STR) is a medical device company that develops technology for...
23 Oct 2015 by Global Data USD $250 More Info

This report is published by MarketsandMarkets

Download Free Report Summary PDF

Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer), Product, and End Users & Region - Global Forecast to 2020 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...